Cargando…

Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets

This study aimed to develop a biopredictive dissolution method for desvenlafaxine ER tablets using design of experiments (DoE) and physiologically based biopharmaceutics modeling (PBBM) to address the challenge of developing generic drug products by reducing the risk of product failure in pivotal bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carapeto, Gustavo Vaiano, Duque, Marcelo Dutra, Issa, Michele Georges, Ferraz, Humberto Gomes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222762/ https://www.ncbi.nlm.nih.gov/pubmed/37242786 http://dx.doi.org/10.3390/pharmaceutics15051544

Ejemplares similares

Development of a Discriminative Dissolution Method, Using In-Silico Tool for Hydrochlorothiazide and Valsartan Tablets
por: Leon, Rosmery Merma, et al.
Publicado: (2023)

Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling
por: Issa, Michele Georges, et al.
Publicado: (2022)

Microemulsions: An Encapsulation Strategy to Increase the Thermal Stability of D-limonene
por: Belem, Bruna Rodrigues, et al.
Publicado: (2023)

In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
por: Bermejo, Marival, et al.
Publicado: (2020)

In Silico Prediction of Plasma Concentrations of Fluconazole Capsules with Different Dissolution Profiles and Bioequivalence Study Using Population Simulation
por: Duque, Marcelo Dutra, et al.
Publicado: (2019)

Hybrid polymeric matrices for oral modified release of Desvenlafaxine succinate tablets
por: Samy, Wael, et al.
Publicado: (2017)

Quality Control Dissolution Data Is Biopredictive for a Modified Release Ropinirole Formulation: Virtual Experiment with the Use of Re-Developed and Verified PBPK Model
por: Shuklinova, Olha, et al.
Publicado: (2022)

Desvenlafaxine Extended-Release in Panic Disorder: A Retrospective Chart Review
por: Min Lee, Sang, et al.
Publicado: (2022)

Biomarkers for the Rich and Dangerous: Why We Ought to Extend Bioprediction and Bioprevention to White-Collar Crime
por: Zohny, Hazem, et al.
Publicado: (2018)

Desvenlafaxine
por: Andrade, Chittaranjan
Publicado: (2009)

Monolithic LC method applied to fesoterodine fumarate low dose extended-release tablets: Dissolution and release kinetics
por: Sangoi, Maximiliano S., et al.
Publicado: (2015)

The impact of viscosity on the dissolution of naproxen immediate-release tablets
por: Hassan, Dastan Salim, et al.
Publicado: (2022)

Hepatocyte-based flow analytical bioreactor for online xenobiotics metabolism bioprediction
por: Helvenstein, M, et al.
Publicado: (2017)

Impact of Tablet Shape on Drug Dissolution Rate Through Immediate Released Tablets
por: Molavi, Fatima, et al.
Publicado: (2020)

The Effect of Biorelevant Hydrodynamic Conditions on Drug Dissolution from Extended-Release Tablets in the Dynamic Colon Model
por: O’Farrell, Connor, et al.
Publicado: (2022)

Fast, Spectroscopy-Based Prediction of In Vitro Dissolution Profile of Extended Release Tablets Using Artificial Neural Networks
por: Galata, Dorián László, et al.
Publicado: (2019)

The Effect of Humidity on the Dissolution Kinetics and Tablet Properties of Immediate-Release Tablet Formulation Containing Lamotrigine
por: Lalić-Popović, Mladena, et al.
Publicado: (2022)

Development and Validation of Discriminative Dissolution Method for Metformin Immediate-Release Film-Coated Tablets
por: Mitrevska, Ivana, et al.
Publicado: (2019)

Advances in ATR-FTIR Spectroscopic Imaging for the Analysis of Tablet Dissolution and Drug Release
por: van Haaren, Céline, et al.
Publicado: (2023)

Desvenlafaxine in the treatment of major depressive disorder
por: Lourenco, Maria Teresa C, et al.
Publicado: (2009)

Monitoring the hydrolyzation of aspirin during the dissolution testing for aspirin delayed-release tablets with a fiber-optic dissolution system
por: Wang, Yan, et al.
Publicado: (2012)

Comparing the Performance of Raman and Near-Infrared Imaging in the Prediction of the In Vitro Dissolution Profile of Extended-Release Tablets Based on Artificial Neural Networks
por: Galata, Dorián László, et al.
Publicado: (2023)

Influence of the Efavirenz Micronization on Tableting and Dissolution
por: Pinto, Eduardo Costa, et al.
Publicado: (2012)

Additive Manufacturing of an Extended-Release Tablet of Tacrolimus
por: Abdollahi, Azin, et al.
Publicado: (2023)

Dissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of Melatonin
por: Chua, Hui Ming, et al.
Publicado: (2016)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
por: Belew, Sileshi, et al.
Publicado: (2020)

Venlafaxine and desvenlafaxine in the management of menopausal hot flashes
por: Johnson, Emily D, et al.
Publicado: (2011)

Dissolution method for delapril and manidipine combination tablets based on an absorption profile of manidipine()
por: Todeschini, Vítor, et al.
Publicado: (2016)

Non-destructive Determination of Disintegration Time and Dissolution in Immediate Release Tablets by Terahertz Transmission Measurements
por: Markl, Daniel, et al.
Publicado: (2017)

In Vivo Relevance of a Biphasic In Vitro Dissolution Test for the Immediate Release Tablet Formulations of Lamotrigine
por: Incecayir, Tuba, et al.
Publicado: (2023)

Relationship Between Dissolution Rate in Vitro and Absorption Rate in Vivo of Ketamine Prolonged-Release Tablets
por: Weiss, Michael
Publicado: (2023)

Development and Validation of New Discriminative Dissolution Method for Carvedilol Tablets
por: Raju, V., et al.
Publicado: (2011)

Metoprolol succinate extended release/hydrochlorothiazide combination tablets
por: Hainer, James W, et al.
Publicado: (2007)

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
por: Jara, Michele, et al.
Publicado: (2013)

Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
por: Umland, Elena M, et al.
Publicado: (2012)

Drug–drug interactions involving antidepressants: focus on desvenlafaxine
por: Low, Yvette, et al.
Publicado: (2018)

Desvenlafaxine-Induced Interstitial Pneumonitis: A Case Report
por: Flora, Arjan, et al.
Publicado: (2018)

Discriminative Dissolution Method Using the Open-Loop Configuration of the USP IV Apparatus to Compare Dissolution Profiles of Metoprolol Tartrate Immediate-Release Tablets: Use of Kinetic Parameters
por: Solis-Cruz, Bruno, et al.
Publicado: (2023)

Automatic Dissolution Testing with High-Temporal Resolution for Both Immediate-Release and Fixed-Combination Drug Tablets
por: Chi, Zhongmei, et al.
Publicado: (2019)

In vitro release studies of furosemide reference tablets: influence of agitation rate, USP apparatus, and dissolution media
por: Medina-López, Raúl, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1mqa0epbtbq4af5nao88mhfhr1